Evaluation of a remote monitoring app in head and neck cancer follow‐up care
Cancer Medicine · 2023-07 · 12 (14) · 15552-15566
DOI: 10.1002/cam4.6202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 09.06.2023. Verfasst von Cecile van de Weerd und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: COVID-19, Mobile Applications, Head and Neck Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
A remote monitoring app was developed for head and neck cancer (HNC) follow‐up during the SARS‐CoV‐2 pandemic. This mixed‐methods study provides insight in the usability and patients' experiences with the app to develop recommendations for future use.
Methods
Patients were invited to participate if they were treated for HNC, used the app at least once and were in clinical follow‐up. A subset was selected for semi‐structured interviews through purposive sampling considering gender and age. This study was conducted between September 2021–May 2022 at a Dutch university medical center.
Results
135 of the 216 invited patients completed the questionnaire, resulting in a total mHealth usability score of 4.72 (± 1.13) out of 7. Thirteen semi‐structured interviews revealed 12 barriers and 11 facilitators. Most of them occurred at the level of the app itself. For example, patients received no feedback when all their answers were normal. The app made patients feel more responsible over their follow‐up, but could not fulfill the need for personal contact with the attending physician. Patients felt that the app could replace some of the outpatient follow‐up visits.
Conclusions
Our app is user‐friendly, makes patients feel more in control and remote monitoring can reduce the frequency of outpatient follow‐up visits. The barriers that emerged must be resolved before the app can be used in regular HNC follow‐up. Future studies should investigate the appropriate ratio of remote monitoring to outpatient follow‐up visits and the cost‐effectiveness of remote monitoring in oncology care on a larger scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands.
ORCID-Profile: Robert P Takes
Zitieren
APA
van de Weerd, C., Ebbers, T., Smilde, D. E. M., van Tol-Geerdink, J. J., Takes, R. P., van den Broek, G. B., Hermens, R. P. M. G., & Kool, R. B. (2023). Evaluation of a remote monitoring app in head and neck cancer follow‐up care. Cancer Medicine, 12(14), 15552-15566. https://doi.org/10.1002/cam4.6202
Vancouver
van de Weerd C, Ebbers T, Smilde DEM, van Tol-Geerdink JJ, Takes RP, van den Broek GB, et al. Evaluation of a remote monitoring app in head and neck cancer follow‐up care. Cancer Medicine. 2023;12(14):15552-15566. doi:10.1002/cam4.6202
BibTeX
@article{vandeWeerd2023,
author = {van de Weerd, Cecile and Ebbers, Tom and Smilde, Donna E M and van Tol-Geerdink, Julia J and Takes, Robert P and van den Broek, Guido B and Hermens, Rosella P M G and Kool, Rudolf B},
title = {Evaluation of a remote monitoring app in head and neck cancer follow‐up care},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {14},
pages = {15552--15566},
doi = {10.1002/cam4.6202}
}
EUVIMED